Content related to Children’s Hospital Los Angeles Researcher Recognized for Contributions in Retinoblastoma Research

Children’s Hospital Los Angeles researchers develop a pediatric solid tumor liquid biopsy for use when obtaining a tissue biopsy is not feasible.

International retinoblastoma research study to begin this summer to investigate liquid biopsy and its use in diagnosing and determining disease severity in retinoblastoma.

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

Findings may lead to better diagnosis and treatment of childhood kidney cancer.

A new study finds that blocking Artemis significantly reduces the proliferation of leukemia cells, without affecting normal cells.

The zebrafish is one of the most powerful biomedical research tools in use today. CHLA is using them to better understand what causes pediatric cancer.

How next-generation gene therapies target the underlying causes of genetic diseases.

Jesse Berry, MD, shares how CHLA’s pioneering liquid biopsy is personalizing care for retinoblastoma.